1. |
Fox JL. Obama catapults patient-empowered precision medicine. Nat Biotechnol, 2015, 33(4): 325.
|
2. |
中华人民共和国国家卫生和计划生育委员会. 肺结核诊断: WS 288-2017, 2017. http://www.nhfpc.gov.cn/ewebeditor/uploadfile/2017/11/20171128164254246.pdf.
|
3. |
中华医学会结核病学分会, 结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017, 40(6): 419-425.
|
4. |
Chakravorty S, Simmons AM, Rowneki M, et al. The new Xpert Mtb/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio, 2017, 8(4): e00812-e00817.
|
5. |
Bhirud P, Joshi A, Hirani N, et al. Rapid laboratory diagnosis of pulmonary tuberculosis. Int J Mycobacteriol, 2017, 6(3): 296-301.
|
6. |
张伟阳, 钟建平, 杨国彪, 等. LAMP和Xpert Mtb/RIF早期诊断肺结核传染源的价值比较. 温州医科大学学报, 2017(1): 61-63.
|
7. |
Nathavitharana RR, Cudahy PG, Schumacher SG, et al. Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2017, 49(1): 1601075.
|
8. |
Meaza A, Kebede A, Yaregal Z, et al. Evaluation of genotype MTBDR plus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect Dis, 2017, 17(1): 280.
|
9. |
Tang P, Wang X, Shen X, et al. Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid. Exp Ther Med, 2017, 13(5): 2332-2338.
|
10. |
Senghore M, Otu J, Witney A, et al. Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria. PLoS One, 2017, 12(9): e0184510.
|
11. |
Wagh V, Urhekar A, Modi D. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy. Tuberculosis (Edinb), 2017, 102: 24-30.
|
12. |
Cui JY, Liang HW, Pan XL, et al. Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals. PLoS One, 2017, 12(9): e0184113.
|
13. |
Verma R, Pinto SM, Patil AH, et al. Quantitative proteomic and phosphoproteomic analysis of H37Ra and H37Rv strains of Mycobacterium tuberculosis. J Proteome Res, 2017, 16(4): 1632-1645.
|
14. |
Ganmaa D, Munkhzul B, Fawzi W, et al. High-dose vitamin D3 during tuberculosis treatment in Mongolia. A randomized controlled trial. Am J Respir Crit Care Med, 2017, 196(5): 628-637.
|
15. |
Azuma J, Ohno M, Kubota R, et al. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy. Eur J Clin Pharmacol, 2013, 69(5): 1091-1101.
|